Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 300.00
Bid: 301.00
Ask: 308.00
Change: -5.00 (-1.64%)
Spread: 7.00 (2.326%)
Open: 306.00
High: 306.00
Low: 300.00
Prev. Close: 305.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreed Revolving Credit Facility

26 Apr 2023 07:00

RNS Number : 4493X
Fisher (James) & Sons plc
26 April 2023
 

This announcement contains inside information

26 April 2023

James Fisher and Sons plc

Agreed Revolving Credit Facility; Q1 ahead of prior year and in line with expectations

 

James Fisher and Sons plc (FSJ.L) ("James Fisher", the "Group"), the leading provider of marine services, announces that it has reached agreement on the terms of a new £210m secured revolving credit facility ("RCF"), which will be provided by its six existing lenders and which matures in March 2025.

 

The RCF will replace the Group's existing four facilities, which total £247.5m and of which £47.5m was due to mature in October 2023. The Group's successful programme of non-core disposals has resulted in continued deleveraging and the new RCF will provide the Group with continued financial flexibility to continue to execute its strategy. The Board is grateful for the expeditious support of its lenders and looks forward to concluding the long-form documentation of the RCF with a longstop date of 7 June 2023 (expected by mid-May and satisfaction of conditions shortly thereafter). The existing waiver in respect of the current £247.5m of borrowing facilities, which was granted following the JFN transaction, has been extended in line with the new RCF process to ensure continued access to funding.

 

The key terms of the new RCF are:

 

- a single, secured, multicurrency RCF facility of £210m with a maturity date of 31 March 2025

- scheduled amortisation requirements in line with the Group's deleveraging plans

- variable margin determined by the level of net leverage from time to time

- appropriate financial covenants, measured on a quarterly basis

 

The Group's FY22 results announcement is scheduled for 28 April 2023. The results for FY22 are in line with previous guidance provided on 24 March 2023 and the Group's trading performance in the first quarter of FY23 is ahead of prior year and in line with the Board's expectations.

 

Jean Vernet, Chief Executive Officer, commented:

 

"We are pleased to have reached this important agreement with our lenders and appreciate their ongoing support. We look forward to completing the final steps of the refinancing over the coming weeks. The Group has traded well in the first quarter of 2023 and we remain focused on delivering further financial and operational improvement."

 

 

For further information:

James Fisher and Sons plc

Jean Vernet

Duncan Kennedy

Chief Executive Officer

Chief Financial Officer

020 7614 9503

FTI Consulting

Richard Mountain

Susanne Yule

0203 727 1340

 

 

The person responsible for making this announcement on behalf of the Company is Jean-François Bauer, Group General Counsel.

 

LEI: 213800J975E5OYR6S216

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBCGDSCXDDGXU
Date   Source Headline
22nd Mar 20224:35 pmRNSHolding(s) in Company
10th Mar 20227:00 amRNSFull year results for the year ended 31 Dec 21
24th Jan 202210:54 amRNSDirector Declaration
29th Dec 20219:55 amRNSMozambique update
17th Dec 20217:00 amRNSAppointment of non-executive director
15th Dec 20215:36 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20215:22 pmRNSHolding(s) in Company
18th Nov 202110:25 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSSale of James Fisher Testing Services for £5.7m
1st Nov 20215:23 pmRNSDirector/PDMR Shareholding
25th Oct 20217:00 amRNSTrading update
22nd Oct 20218:00 amRNSAppointment of non-executive director
15th Sep 20211:26 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf year results for the 6 months ended 30 Jun 21
1st Jul 20217:00 amRNSSale of Paladin for US$17.3m
29th Jun 20217:00 amRNSCapital Markets Event & Pre Close Trading Update
15th Jun 20213:51 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jun 20214:16 pmRNSDirector/PDMR Shareholding
30th Apr 202111:59 amRNSDirector Declaration
29th Apr 20212:01 pmRNSResult of Annual General Meeting
29th Apr 20217:00 amRNSAGM Trading Statement
20th Apr 20217:00 amRNSAppointment of Chief Financial Officer
13th Apr 202111:32 amRNSWithdrawal of Annual General Meeting Resolution
9th Apr 202110:18 amRNSDirector/PDMR Shareholding
8th Apr 20213:58 pmRNSDirector/PDMR Shareholding
6th Apr 20213:48 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights and Share Capital
29th Mar 20217:00 amRNSDirectorate Change
23rd Mar 202112:58 pmRNSAnnual Report and Notice of AGM posted
19th Mar 20211:17 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSResults for the year ended 31 December 2020
25th Feb 202110:42 amRNSNotification of FY Results Date
25th Jan 20217:00 amRNSAngus Cockburn appointed as Chairman
7th Jan 20217:00 amRNSPost close trading update
18th Dec 20204:41 pmRNSSecond Price Monitoring Extn
18th Dec 20204:35 pmRNSPrice Monitoring Extension
15th Dec 202011:18 amRNSBLOCK LISTING SIX MONTHLY RETURN
11th Nov 20207:00 amRNSDirector/PDMR Shareholding
9th Nov 20205:25 pmRNSTotal Voting Rights
6th Nov 20207:00 amRNSTrading Update
2nd Nov 20207:00 amRNSTotal Voting Rights
23rd Oct 20209:48 amRNSDirector/PDMR Shareholding
6th Oct 20203:58 pmRNSDirector/PDMR Shareholding
2nd Oct 20207:00 amRNSRoyal Navy contract award
21st Sep 20204:00 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSHalf-year results
24th Jul 202012:00 pmRNSDirector/PDMR Shareholding
7th Jul 20207:00 amRNSHalf year post close trading update
24th Jun 202012:02 pmRNSPrice Monitoring Extension
15th Jun 20207:00 amRNSBLOCK LISTING SIX MONTHLY RETURN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.